Related Experiment Video
Updated: May 2, 2026

18:11
Microfluidic Chips Controlled with Elastomeric Microvalve Arrays
Published on: October 1, 2007
21.9K
A novel laminar flow-based hierarchical microfluidic (LF-HM) chip for multiplex detection without cross-talk
Xiaohui Yang1, Yixian Li1, Shanshan Cheng2
1Department of Clinical Immunology, School of Medical Technology, Tianjin Medical University, Tianjin, 300203, PR China.
Talanta
|February 28, 2026
Summary
This study introduces a novel microfluidic chip that eliminates assay cross-talk for cost-effective, point-of-care diagnostics. The laminar flow-based hierarchical microfluidic (LF-HM) chip enables multiplexed testing by separating incompatible assays vertically within a single channel.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Microfluidics
Background:
- Microfluidic devices offer potential for cost-effective, point-of-care diagnostics with reduced reagent use.
- Assay cross-talk in multiplexed microfluidic systems hinders the integration of incompatible detection methods.
Purpose of the Study:
- To develop a novel microfluidic chip addressing cross-talk challenges in multiplexed diagnostics.
- To enable reliable, integrated point-of-care testing by isolating incompatible assays.
Main Methods:
- A laminar flow-based hierarchical microfluidic (LF-HM) chip was designed and simulated using finite element analysis.
- Experimental validation involved characterizing laminar flow stability, determining optimal operating temperature, and assessing cross-talk elimination.
- The chip's performance was evaluated by integrating rheumatoid factor (RF) and anti-citrullinated protein antibody (ACPA) assays.
Main Results:
- Finite element simulations confirmed the chip's fluid handling capabilities and minimal flow disturbance.
- Stable laminar flow was achieved, with an optimal operating temperature range of 15-26°C identified to minimize diffusion.
- Complete cross-talk elimination was demonstrated, with integrated RF and ACPA assays showing excellent analytical agreement and strong correlation with reference methods in clinical validation.
Conclusions:
- The LF-HM chip provides a robust and generalizable solution for cross-talk-free multiplexed diagnostics.
- This technology has broad potential for advancing point-of-care diagnostic devices, overcoming limitations of previous integrated assay designs.

